A case-control review of placentas from patients with intrahepatic cholestasis of pregnancy

Fetal Pediatr Pathol. 2014 Aug;33(4):210-5. doi: 10.3109/15513815.2014.899413. Epub 2014 Apr 23.

Abstract

Objective: To compare the incidence of histopathological features in placentas from women with cholestasis of pregnancy to healthy individuals without ICP.

Methods: Placentas from mothers with and without cholestasis of pregnancy were reviewed by a pathologist masked to the study group. Subjects were excluded if they had medical problems already associated with placental histopathology.

Results: Twenty-four cases and 30 controls placentas were reviewed. Seventeen placental histopathological features were found. There was no statistically significant difference between the groups. Amongst patients with cholestasis, there was a decrease in villitis of unknown etiology in those treated with ursodeoxycholic acid.

Conclusion: There is no difference in the placental histopathology in cholestasis of pregnancy compared to normal pregnancies, but treatment of patients with cholestasis of pregnancy with ursodeoxycholic acid may decrease findings of villitis of unknown etiology.

Keywords: cholestasis; intrahepatic; placenta; pregnancy; ursodeoxycholic acid.

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / pharmacology
  • Case-Control Studies
  • Cholestasis, Intrahepatic / drug therapy
  • Cholestasis, Intrahepatic / pathology*
  • Chorionic Villi / pathology
  • Female
  • Humans
  • Infant, Newborn
  • Placenta / drug effects
  • Placenta / pathology*
  • Placenta Diseases / pathology
  • Placenta Diseases / prevention & control
  • Pregnancy
  • Pregnancy Complications / drug therapy
  • Pregnancy Complications / pathology*
  • Ursodeoxycholic Acid / therapeutic use
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Ursodeoxycholic Acid

Supplementary concepts

  • Intrahepatic Cholestasis of Pregnancy